[96a5a0]: / output / allTrials / identified / NCT00460694_identified.json

Download this file

246 lines (246 with data), 10.5 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
{
"info": {
"nct_id": "NCT00460694",
"official_title": "A Phase II Trial on Allogeneic Cytokine-induced Killer Cell Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies",
"inclusion_criteria": "This trial includes only patients who have relapsed after an allogeneic transplant, who have either:\n\n1. No response to conventional DLI given for at least one dose, or\n2. No possibility of access to large number of donor lymphocyte for repeated doses of DLI, This applies to cases of unrelated transplant or cord blood transplant\n3. Patients who developed significant GVHD to conventional DLI, but had no other therapeutic option. In such cases the rationale is based on mice studies of mismatched CIK producing much less GVHD than mismatched unmanipulated splenocytes.\n\nIn view of the period taken to culture the cell to maturity, patient must have a life expectancy of more than one month. Interim measures eg chemotherapy or conventional DLI will be given during the interval so that ongoing treatment will not be compromised in any way.\nHealthy volunteers allowed\nMust have minimum age of 12 Years\nMust have maximum age of 60 Years",
"exclusion_criteria": "1. Uncontrolled infection or significant bleeding\n2. Unstable vital signs\n3. Any degree of hypoxia requiring oxygen therapy.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "This trial includes only patients who have relapsed after an allogeneic transplant, who have either:",
"criterions": [
{
"exact_snippets": "relapsed after an allogeneic transplant",
"criterion": "relapse after allogeneic transplant",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "1. No response to conventional DLI given for at least one dose, or",
"criterions": [
{
"exact_snippets": "No response to conventional DLI given for at least one dose",
"criterion": "response to conventional DLI",
"requirements": [
{
"requirement_type": "response",
"expected_value": false
},
{
"requirement_type": "dose",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "dose"
}
}
]
}
]
},
{
"line": "2. No possibility of access to large number of donor lymphocyte for repeated doses of DLI, This applies to cases of unrelated transplant or cord blood transplant",
"criterions": [
{
"exact_snippets": "No possibility of access to large number of donor lymphocyte for repeated doses of DLI",
"criterion": "access to donor lymphocyte",
"requirements": [
{
"requirement_type": "possibility",
"expected_value": false
}
]
},
{
"exact_snippets": "unrelated transplant",
"criterion": "transplant type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "unrelated"
}
]
},
{
"exact_snippets": "cord blood transplant",
"criterion": "transplant type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "cord blood"
}
]
}
]
},
{
"line": "3. Patients who developed significant GVHD to conventional DLI, but had no other therapeutic option. In such cases the rationale is based on mice studies of mismatched CIK producing much less GVHD than mismatched unmanipulated splenocytes.",
"criterions": [
{
"exact_snippets": "Patients who developed significant GVHD to conventional DLI",
"criterion": "significant GVHD to conventional DLI",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "had no other therapeutic option",
"criterion": "other therapeutic option",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "In view of the period taken to culture the cell to maturity, patient must have a life expectancy of more than one month. Interim measures eg chemotherapy or conventional DLI will be given during the interval so that ongoing treatment will not be compromised in any way.",
"criterions": [
{
"exact_snippets": "patient must have a life expectancy of more than one month",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "month"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 12 Years",
"criterions": [
{
"exact_snippets": "minimum age of 12 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 12,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 60 Years",
"criterions": [
{
"exact_snippets": "maximum age of 60 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 60,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Uncontrolled infection or significant bleeding",
"criterions": [
{
"exact_snippets": "Uncontrolled infection",
"criterion": "infection",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "significant bleeding",
"criterion": "bleeding",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "significant"
}
]
}
]
},
{
"line": "2. Unstable vital signs",
"criterions": [
{
"exact_snippets": "Unstable vital signs",
"criterion": "vital signs",
"requirements": [
{
"requirement_type": "stability",
"expected_value": "unstable"
}
]
}
]
},
{
"line": "3. Any degree of hypoxia requiring oxygen therapy.",
"criterions": [
{
"exact_snippets": "Any degree of hypoxia requiring oxygen therapy.",
"criterion": "hypoxia",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "any degree"
},
{
"requirement_type": "treatment",
"expected_value": "oxygen therapy"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}